Jiefei Han

Beijing, 101149, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Targeting Classical EGFR Mutations in Lung Cancer: Twenty Years of Progress and Beyond.

Targeting Classical EGFR Mutations in Lung Cancer: Twenty Years of Progress and Beyond.

Journal: Cancers
Published: June 15, 2026

Is TROP2 ADC ready for EGFR-TKI-resistant NSCLC?

Is TROP2 ADC ready for EGFR-TKI-resistant NSCLC?

Journal: Translational lung cancer research
Published: March 20, 2026

Augmenting LLM with Prompt Engineering and Supervised Fine-Tuning in NSCLC TNM Staging: Framework Development and Validation.

Augmenting LLM with Prompt Engineering and Supervised Fine-Tuning in NSCLC TNM Staging: Framework Development and Validation.

Journal: JMIR AI
Published: February 04, 2026

Augmenting Large Language Model With Prompt Engineering and Supervised Fine-Tuning in Non-Small Cell Lung Cancer Tumor-Node-Metastasis Staging: Framework Development and Validation.

Augmenting Large Language Model With Prompt Engineering and Supervised Fine-Tuning in Non-Small Cell Lung Cancer Tumor-Node-Metastasis Staging: Framework Development and Validation.

Journal: JMIR AI
Published: May 23, 2025

Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.

Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.

Journal: Nature communications
Published: February 24, 2025

Bruton's tyrosine kinase inhibitor zanubrutinib-based regimens in relapsed/refractory primary diffuse large B-cell lymphoma of the central nervous system.

Bruton's tyrosine kinase inhibitor zanubrutinib-based regimens in relapsed/refractory primary diffuse large B-cell lymphoma of the central nervous system.

Journal: Leukemia & lymphoma
Published: January 17, 2025

Associations of Pap test utilisation with comorbidity and functional impairment among middle-aged non-Hispanic black women in the USA: a cross-sectional analysis of the 2018 BRFSS data.

Associations of Pap test utilisation with comorbidity and functional impairment among middle-aged non-Hispanic black women in the USA: a cross-sectional analysis of the 2018 BRFSS data.

Journal: BMJ open
Published: July 25, 2024

Primary brainstem lymphoma: clinical characteristics, treatment methods, and prognostic factors of 56 patients.

Primary brainstem lymphoma: clinical characteristics, treatment methods, and prognostic factors of 56 patients.

Journal: The oncologist
Published: May 06, 2024

Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World).

Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World).

Journal: The Journal of thoracic and cardiovascular surgery
Published: October 17, 2023

Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.

Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.

Journal: Nature communications
Published: March 17, 2023

Case report: The treatment for olfactory neuroblastoma combined with leptomeningeal carcinomatosis via an ommaya reservoir.

Case report: The treatment for olfactory neuroblastoma combined with leptomeningeal carcinomatosis via an ommaya reservoir.

Journal: Frontiers in oncology
Published: October 03, 2022

Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.

Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.

Journal: EBioMedicine
Published: January 20, 2022
Showing 1-12 of 21

Last Updated: 09/26/2026